The impact of testing and treatment on the dynamics of Hepatitis B virus

NameWorld Continuing Education Alliance
Activity TitleThe impact of testing and treatment on the dynamics of Hepatitis B virus
DetailsHepatitis is an inflammation/scarring of the liver that contributes to various health complications, including death. It occurs due to an immune system attack by the virus in the liver and damages this vital organ of the body in the process (. In highly endemic areas, the most common form of transmission of hepatitis B is from mother to child at birth (vertical transmission) or through horizontal route (contact with infected blood), particularly from infected children to uninfected children during the first five years of life. Chronic infection develops in infants infected by their mothers or before the age of five. It is often transmitted through transdermal or mucosal contact of infected persons to infected blood and different body fluids, such as spittle, catamenial, vaginal and spermatic fluids and, to a lesser degree, perspiration, breast milk, tears, and urine. In particular, hepatitis B can be transmitted through sexual contact in unvaccinated men who have sex with men (MSM) and... Objectives Course Objective Despite the intervention of WHO on vaccination for reducing the spread of Hepatitis B Virus (HBV), there are records of the high prevalence of HBV in some regions. In this paper, a mathematical model was formulated to analyze the acquisition and transmission process of the virus with the view of identifying the possible way of reducing the menace and mitigating the risk of the virus. The models' positivity and boundedness were demonstrated using well-known theorems. Equating the differential equations to zero demonstrates the equilibria of the solutions i.e., the disease-free and endemic equilibrium.
CompetenceGeneral Medicine
Start Date<span class="not-set">(not set)</span>
End Date<span class="not-set">(not set)</span>
Event Time02:30 PM
LocationWorld Continuing Education Alliance eLearning System
Cost (UGX)0
CPD Points1